BHCM
MLAB icon

Brevan Howard Capital Management’s Mesa Laboratories MLAB Stock Holding History

Brevan Howard Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Buy
+4,489
New +$452K ﹤0.01% 1503
2025
Q4 		– Sell
-5,977
Closed -$401K – 2108
2025
Q3 		$401K Buy
5,977
+3,678
+160% +$265K ﹤0.01% 1402
2025
Q2 		$217K Buy
+2,299
New +$252K ﹤0.01% 1683

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Brevan Howard Capital Management's MLAB Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Mesa Laboratories (MLAB) in Q2 2026: 4,489 shares worth $447K. The stake represents ﹤0.01% of the portfolio and ranks #1503 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in MLAB as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in MLAB in Q2 2025 and has held it in 3 quarters since. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Brevan Howard Capital Management held 4,489 shares of Mesa Laboratories worth $447K as of Q2 2026.
  • Mesa Laboratories was a new Brevan Howard Capital Management position in Q2 2026.
  • Mesa Laboratories made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1503 holding.
  • Brevan Howard Capital Management first reported a position in Mesa Laboratories in Q2 2025 and has held it in 3 quarters since.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.